"10.1371_journal.pone.0030325","plos one","2012-03-14T00:00:00Z","Thierry Poynard; Guillaume Lassailly; Emmanuel Diaz; Karine Clement; Robert Caïazzo; Joan Tordjman; Mona Munteanu; Hugo Perazzo; Bernard Demol; Robert Callafe; François Pattou; Frederic Charlotte; Pierre Bedossa; Philippe Mathurin; Vlad Ratziu; for the FLIP consortium","APHP UPMC Liver Center, Paris, France; Hepatology Department, Centre Hospitalier Lille, Lille, France; Hepatology Department, Centre Hospitalier Bethune, Bethune, France; Institute of Cardiometabolisme and Nutrition, APHP Pitié-Salpêtrière Hospital, Paris, France; INSERM, U872, Nutriomique, Paris, France; Université Pierre et Marie Curie-Paris 6, Centre de Recherche des Cordeliers, Paris, France; Biopredictive, Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital Beaujon, Département de Pathologie Clichy, Clichy, France","Conceived and designed the experiments: TP PM ED KC VR. Performed the experiments: TP. Analyzed the data: TP PM FC HP VR PB GL. Contributed reagents/materials/analysis tools: ED MM BD FP FC R. Caïazzo R. Callafe JT. Wrote the paper: TP PM VR FC.","TP, the inventor of patented FibroTest, Actitest, SteatoTest, NashTest and AshTest, is a consultant and has a capital interest in Biopredictive, the company marketing these tests. The patents belong to the French Public Organization “Assistance Publique Hopitaux de Paris”. MM is full employee of Biopredictive. The patents' number are (date): FibroTest: 7,225,080 (May 29, 2007); SteatoTest: 7,860,656 (December 28, 2010); and AshTest: 7,856,319 (December 21, 2010). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Thierry Poynard","TP",16,TRUE,5,1,7,4,TRUE,TRUE,TRUE,1,"6",FALSE
